LINC01315 accelerates the growth and epithelial-mesenchymal transition of colorectal cancer cells via activating the Wnt/β-catenin signal

References

• Li Q, Lai Q, He C, et al. RUNX1 promotes tumour metastasis by activating the Wnt/beta-catenin signalling pathway and EMT in colorectal cancer. J Exp Clin Cancer Res. 2019;38(1):334.
   PubMed Web of Science ®Google Scholar
• Zhang H, Fang Z, Guo Y, et al. Long noncoding RNA SNHG10 promotes colorectal cancer cells malignant progression by targeting miR-3690. Bioengineered. 2021;12(1):6010–6020.
   PubMed Web of Science ®Google Scholar
• Oki E, Ando K, Nakanishi R, et al. Recent advances in treatment for colorectal liver metastasis. Ann Gastroenterol Surg. 2018;2(3):167–175.
   PubMed Web of Science ®Google Scholar
• Chen P, Yao Y, Yang N, et al. Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cell Death Dis. 2020;11(7):557.
   PubMed Web of Science ®Google Scholar
• Zhang M, Miao F, Huang R, et al. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. J Exp Clin Cancer Res. 2018;37:22.
   PubMed Web of Science ®Google Scholar
• Liu R, Deng P, Zhang Y, et al. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/beta-catenin pathway. World J Surg Oncol. 2021;19(1):51.
   PubMed Web of Science ®Google Scholar
• Jiang S, Li Q, Liu Y, et al. Activation of WNT7b autocrine eases metastasis of colorectal cancer via epithelial to mesenchymal transition and predicts poor prognosis. BMC Cancer. 2021;21(1):180.
   PubMed Web of Science ®Google Scholar
• Sacchetti A, Teeuwssen M, Verhagen M, et al. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. Elife. 2021;10. DOI:10.7554/eLife.61461.
   PubMed Web of Science ®Google Scholar
• Yu F, Yu C, Li F, et al. Wnt/beta-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.
   PubMed Web of Science ®Google Scholar
• Chen M, Li L, Zheng PS. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1. Cancer Sci. 2019;110(9):2794–2805.
   PubMed Web of Science ®Google Scholar
• Ye Y, Gu B, Wang Y, et al. YY1-induced upregulation of long noncoding RNA ARAP1-AS1 promotes cell migration and invasion in colorectal cancer through the Wnt/beta-catenin signaling pathway. Cancer Biother Radiopharm. 2019;34(8):519–528.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60.
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/beta-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473–481.
   PubMed Web of Science ®Google Scholar
• Wang CG, Hu YH, Su SL, et al. LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/beta-catenin signaling pathway. Exp Mol Med. 2020;52(8):1310–1325.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/beta-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12(1):162–171.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wu J, Li Y, et al. Long non-coding RNA FENDRR inhibits the stemenss of colorectal cancer cells through directly binding to Sox2 RNA. Bioengineered. 2021;12(1):8698–8708.
   PubMed Web of Science ®Google Scholar
• Deng SJ, Chen HY, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37(44):5811–5828.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang M, Li F. LncRNA AY343892 inhibits breast cancer development by positively regulating BRCA1-mediated transcription of PTEN. Histol Histopathol. 2020;35(10):1171–1180.
   PubMed Web of Science ®Google Scholar
• Xue J, Huang S, Chen J, et al. Overexpression of long non-coding RNA Linc01315 predicts poor prognosis in breast cancer. Front Oncol. 2021;11:562378.
   PubMed Web of Science ®Google Scholar
• Ren J, Zhang FJ, Wang JH, et al. LINC01315 promotes the aggressive phenotypes of papillary thyroid cancer cells by sponging miR-497-5p. Kaohsiung J Med Sci. 2021;37(6):459–467.
   PubMed Web of Science ®Google Scholar
• Liang R, Zhang J, Zhang RM, et al. LINC01315 silencing inhibits the aggressive phenotypes of colorectal carcinoma by sponging miR-205-3p. Biochem Biophys Res Commun. 2021;534:1033–1039.
   PubMed Web of Science ®Google Scholar
• Wang L, Wei Z, Wu K, et al. Long noncoding RNA B3GALT5-AS1 suppresses colon cancer liver metastasis via repressing microRNA-203. Aging (Albany NY). 2018;10(12):3662–3682.
   PubMedGoogle Scholar
• Yue B, Liu C, Sun H, et al. A positive feed-forward loop between LncRNA-CYTOR and Wnt/beta-catenin signaling promotes metastasis of colon cancer. Mol Ther. 2018;26(5):1287–1298.
   PubMed Web of Science ®Google Scholar
• Fu D, Ren Y, Wang C, et al. LINC01287 facilitates proliferation, migration, invasion and EMT of colon cancer cells via miR-4500/MAP3K13 pathway. BMC Cancer. 2021;21(1):782.
   PubMed Web of Science ®Google Scholar
• Lin G, He X, Ji H, et al. Reproducibility probability score–incorporating measurement variability across laboratories for gene selection. Nat Biotechnol. 2006;24(12):1476–1477.
   PubMed Web of Science ®Google Scholar
• Marisa L, de Reynies A, Duval A, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453.
   PubMed Web of Science ®Google Scholar
• Shan Z, An N, Qin J, et al. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/beta-catenin signaling. Biomed Pharmacothe. 2018;101:769–776.
   PubMed Web of Science ®Google Scholar
• Galamb O, Kalmar A, Sebestyen A, et al. Promoter hypomethylation and increased expression of the long non-coding RNA LINC00152 support colorectal carcinogenesis. Pathol Oncol Res. 2020;26(4):2209–2223.
   PubMed Web of Science ®Google Scholar
• Yue B, Cai D, Liu C, et al. Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Mol ther. 2016;24(12):2064–2077.
   PubMed Web of Science ®Google Scholar
• Zeng JH, Liang L, He RQ, et al. Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma. Oncotarget. 2017;8(10):16811–16828.
   PubMedGoogle Scholar
• Tian S, Peng P, Li J, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin signaling pathway. Aging (Albany NY). 2020;12(4):3574–3593.
   PubMedGoogle Scholar
• Huang H, Fan X, Zhang X, et al. LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/beta-catenin and JAK2/STAT3 signaling pathways. Transl Androl Urol. 2020;9(5):2251–2261.
   PubMed Web of Science ®Google Scholar
• Chen FB, Wu P, Zhou R, et al. LINC01315 impairs microRNA-211-Dependent DLG3 downregulation to inhibit the development of oral squamous cell carcinoma. Front Oncol. 2020;10:556084.
   PubMed Web of Science ®Google Scholar
• Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18(1):206.
   PubMed Web of Science ®Google Scholar
• Zhu P, He F, Hou Y, et al. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene. 2021;40(9):1609–1627.
   PubMed Web of Science ®Google Scholar